Decreased expression of survivin, estrogen and progesterone receptors in endometrial tissues after radiofrequency treatment of dysfunctional uterine bleeding

详细信息    查看全文

• 作者：Geping Yin (1)
  Tongyu Zhu (1)
  Juan Li (1)
  Ming Chen (1)
  Shujun Yang (1)
  Xiaoli Zhao (1)
  
• 关键词：Dysfunctional uterine bleeding (DUB) ; Radiofrequency endometrial ablation (REA) ; Survivin ; Estrogen receptor (ER) ; Progesterone receptor (PR)
• 刊名：World Journal of Surgical Oncology
• 出版年：2012
• 出版时间：December 2012
• 年：2012
• 卷：10
• 期：1
• 全文大小：318KB
• 参考文献：1. Amir E, Richard HS: Dysfunctional uterine bleeding. 2010.
  2. Apgar BS, Kaufman AH, George-Nwogu U, Kittendorf A: Treatment of menorrhagia. / Am Fam Physician 2007, 75:1813-819.
  3. Hodgson DA, Feldberg IB, Sharp N, Cronin N, Evans M, Hirschowitz L: Microwave endometrial ablation: development, clinical trials and outcomes at three years. / Br J Obstet Gynecol 1999, 106:684-94. CrossRef
  4. Li D: The curative effect of RU486 for the treatment of dysfunctional uterine bleeding (in Chinese - English abstract available). / Chin J Mod Drug Appl 2009, 3:104-05.
  5. Xiu-min F: Clinical analysis of mifepristone treatment of 68 cases of perimenopausal dysfunctional uterine bleeding (in Chinese - English abstract available). / Medical Information 2010, 23:905-06.
  6. Zarek S, Sharp HT: Global endometrial ablation devices. / Clin Obstet Gynecol 2008, 51:167-75. CrossRef
  7. Taskin O, Onoglu A, Inal M, Turan E, Sadik S, Vardar E, Postaci H, Wheeler JM: Long-term histopathologic and morphologic changes after thermal endometrial ablation. / J Am Assoc Gynecol Laparosc 2002, 9:186-90. CrossRef
  8. Thijssen RF: Radiofrequency induced endometrial ablation: an update. / Br J Obstet Gynaecol 1997, 104:608-13. CrossRef
  9. Dequesne JH, Gallinat A, Garza-Leal JG, Sutton CJ, van der Pas HF, Wamsteker K, Chandler JG: Thermoregulated radiofrequency endometrial ablation. / Int J Fertil Womens Med 1997, 42:311-18.
  10. Clark TJ, Samuel N, Malick S, Middleton LJ, Daniels J, Gupta JK: Bipolar radiofrequency compared with thermal balloon endometrial ablation in the office: a randomized controlled trial. / Obstet Gynecol 2011, 117:109-18. CrossRef
  11. El-Nashar SA, Hopkins MR, Creedon DJ, Cliby WA, Famuyide AO: Efficacy of bipolar radiofrequency endometrial ablation vs thermal balloon ablation for management of menorrhagia: A population-based cohort. / J Minim Invasive Gynecol 2009, 16:692-99. CrossRef
  12. Yin GP, Chen M, Shao X, Zhu TY, Wang YZ: Radiofrequency minimally invasive treatment of uterine benign diseases (in Chinese - English abstract available). / Progress Obstetrics and Gynecology 2003, 12:200-03.
  13. Higham JM, O’Brien PM, Shaw RW: Assessment of menstrual blood loss using a pictorial chart. / BJOG 1990, 97:734-39. CrossRef
  14. Takai N, Miyazaki T, Nishida M, Nasu K, Miyakawa I: Survivin expression correlates with clinical stage, histological grade, invasive behavior and survival rate in endometrial carcinoma. / Cancer Lett 2002, 184:105-16. CrossRef
  15. Chen X, Zhang Z, Feng Y, Fadare O, Wang J, Ai Z, Jin H, Gu C, Zheng W: Aberrant survivin expression in endometrial hyperplasia: another mechanism of progestin resistance. / Modern Pathology 2009, 22:699-08. CrossRef
  16. Hu K, Zhong G, He F: Expression of estrogen receptors ERalpha and ERbeta in endometrial hyperplasia and adenocarcinoma. / Int J Gynecol Cancer 2005, 15:537-41. CrossRef
  17. Kalogiannidis I, Bobos M, Papanikolaou A, Makedos A, Amplianitis I, Vergote I, Nenopoulou E, Makedos G: Immunohistochemical bcl-2 expression, p53 overexpression, PR and ER status in endometrial carcinoma and survival outcomes. / Eur J Gynaecol Oncol 2008, 29:19-5.
  
• 作者单位：Geping Yin (1)
  Tongyu Zhu (1)
  Juan Li (1)
  Ming Chen (1)
  Shujun Yang (1)
  Xiaoli Zhao (1)
  
  1. Department of Obstetrics & Gynecology, Jinan Military General Hospital, #25 Shifan Road, Jinan, 250031, China
  

文摘

Background The purpose of the research is to study the histopathology and expression of survivin, estrogen and progesterone receptors (ER/PR) in the endometrium of patients with dysfunctional uterine bleeding (DUB) treated with radiofrequency endometrial ablation (REA). Methods A total of 98 DUB patients were enrolled in this case–control study. Among them, 66 underwent REA treatment and 32 optioned for hormone therapy as the control group. Immunohistochemical analysis for survivin, ER and PR expression was carried out on endometrial tissue samples collected before and 6 to 7?months after treatment for both groups. Results Both hormone and REA treatment ameliorated menstrual bleeding of DUB patients, with the latter showing a significantly higher effective rate. Endometrial surface tissue was replaced by fibrosis tissue in the REA treatment group. REA treatment also significantly reduced the expression of survivin, ER, and PR. Endometrial surface tissues collected from the hormone-treated control group neither showed any apparent morphological alteration nor in the expression of those receptors. Conclusions REA treatment changed endometrial surface tissue type from gland rich to gland poor, and significantly decreased the expression of survivin, ER, and PR. This may be an important contributing mechanism for the long-term curative effect and prevention of DUB recurrence.